Skip to main content
. 2022 Jul 21;29:370–383. doi: 10.1016/j.omtn.2022.07.014

Figure 5.

Figure 5

Optimizing DAC treatment condition using Am-MC

(A) Absorbance change of Am-MC upon addition of 2 μg of RNase T1-treated RNAs extracted from CAOV3 (left) or A375 (right) cells treated with DAC (1 μM for CAOV3 and 5 μM for A375). The average of three biological replicates is shown with error bars indicating SD. (B) Expression of eight selected ERV RNAs quantified by RT-qPCR. The average of three biological replicates is shown with error bars indicating SD. (C) The correlation between the cell viability and the absorbance change of Am-MC for two different treatment conditions. Vertical error bars (n = 4) and horizontal error bars (n = 3) were expressed as SD.